Curated News
By: NewsRamp Editorial Staff
April 11, 2025
SaveRxCanada.to Provides Affordable Access to Life-Extending Lung Cancer Drug Tagrisso
TLDR
- Accessing life-extending lung cancer drug Tagrisso through SaveRxCanada.to offers U.S. patients monthly savings of $5,500 USD, potentially saving over $66,000 USD annually.
- SaveRxCanada.to connects patients with licensed suppliers in India to provide Tagrisso at $416.67 USD per tablet, significantly reducing the monthly cost compared to U.S. prices.
- SaveRxCanada.to's affordable Tagrisso prices improve access to life-saving treatment, ensuring safety, authenticity, and substantial cost savings for patients.
- Tagrisso, a breakthrough lung cancer therapy, targets specific mutations with improved survival outcomes and quality of life, offering hope to patients worldwide.
Impact - Why it Matters
This news matters as it highlights a breakthrough in making expensive cancer treatments more accessible and affordable for U.S. patients. By offering Tagrisso at a fraction of the U.S. price, SaveRxCanada.to is providing a vital service that could potentially save patients thousands of dollars annually while ensuring safety and authenticity of the medication.
Summary
SaveRxCanada.to, an international online pharmacy, is helping U.S. patients access the lung cancer drug Tagrisso at reduced prices through licensed suppliers in India, saving up to $5,500 USD monthly. Tagrisso, a targeted therapy by AstraZeneca, treats non-small cell lung cancer with EGFR mutations, offering improved survival outcomes. Patients can order Tagrisso through SaveRxCanada.to's certified suppliers for substantial cost savings.
Source Statement
This curated news summary relied on this press release disributed by 24-7 Press Release. Read the source press release here, SaveRxCanada.to Provides Affordable Access to Life-Extending Lung Cancer Drug Tagrisso
